Back to SearchLive NSE/BSEBSE_TASIS Verified
GLENMARK
NSEHealthcareCap: ₹64874.98 CrGlenmark Pharmaceuticals Ltd.
+13.56%YTD
Shariah Compliant (Halal)
Evaluated using BSE_TASIS criteria
Purification Factor0.25%
Market Fundamentals
Market Cap
₹64874.98 CrP/E Ratio
36.1xP/B Ratio
6.2x52W High
₹2,537.652W Low
₹1,801.4Div. Yield
11.00%Shares O/S
28.22 CrWhere Does the Money Come From?
Revenue breakdown for Glenmark Pharmaceuticals Ltd.
Core Healthcare OperationsPermissible Operating Activity
Permissible: Core operations in Healthcare.
99.8%of Total Revenue
Treasury Interest & Secondary Non-Operating IncomeImpure Interest Income (Riba)
Non-operating interest income earned from cash and fixed deposits. Requires purification.
0.2%of Total Revenue
About Glenmark Pharmaceuticals Ltd.
Permissible: Core operations in Healthcare.
Interest-Bearing Debt Ratio
2.98%Max: ≤ 33.0%
Cash & Securities Liquidity
6.03%Max: ≤ 33.0%
Impure Revenue Ratio
0.25%Max: ≤ 5.0%
Screening Denominator
Total Assets
Other Halal Stocks in Healthcare
Similar companies that also pass Shariah screening
Purification & Zakat Calculator
Calculate how much to donate for GLENMARK
How do you know your dividend amount?
0.25% of Gross Dividend
Gross Dividend₹1,000
Give Away as Sadaqah₹2.5Give this away without expecting reward
Your Clean Earnings₹997.5This is fully yours to keep